| 0:00:00 | i everyone well as follows peace amount from the market cancer centre in tampa florida |
|---|
| 0:00:06 | like to talk to you today about a recent review article which my colleagues and |
|---|
| 0:00:10 | i have written for the present journal |
|---|
| 0:00:14 | in the current article we really highlighted a lot of the advances which eliminate in |
|---|
| 0:00:19 | the management of your with your course to know |
|---|
| 0:00:21 | as you all know for the most part of the results of current study regiments |
|---|
| 0:00:26 | and interpersonal sequence have been somewhat disappointing and we really haven't seen any improvements in |
|---|
| 0:00:31 | outcomes over the past ten to fifteen years |
|---|
| 0:00:34 | however i we highlight in this present review article |
|---|
| 0:00:37 | there are some kurt new advances which have been made in the management so you're |
|---|
| 0:00:42 | if you carcinoma |
|---|
| 0:00:43 | and this can be broken down in the measurement of |
|---|
| 0:00:46 | localised these |
|---|
| 0:00:47 | in the form of interpersonal treatments |
|---|
| 0:00:49 | and similarly advancement in the management of more advanced disease uniform a systemic therapies or |
|---|
| 0:00:55 | which consist of either systemic chemotherapy or target regions |
|---|
| 0:01:00 | i think is important to know that there are some current regimens which'll quite exciting |
|---|
| 0:01:04 | and are important to keep abreast as we attempt to improve the outcomes or patients |
|---|
| 0:01:09 | in the months and years to come thank you very much |
|---|